share_log

TScan Therapeutics | 8-K: TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

SEC ·  Nov 13, 2024 01:26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more